![Nate Demars](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nate Demars
Corporate Officer/Principal bij
AKTIS ONCOLOGY, INC.
Profiel
Nate Demars is Vice President & Head-Clinical Operations at Aktis Oncology, Inc. since 2024.
Former roles include Senior Director-Clinical Operations at Alaunos Therapeutics, Inc. and Senior Director-Clinical Operations at Neogene Therapeutics, Inc. Education includes graduate studies at the University of Connecticut and undergraduate studies at the University of New Hampshire.
Actieve functies van Nate Demars
| Bedrijven | Functie | Begin |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Corporate Officer/Principal | 01-09-2024 |
Eerdere bekende functies van Nate Demars
| Bedrijven | Functie | Einde |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Corporate Officer/Principal | - |
Opleiding van Nate Demars
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
21
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Neogene Therapeutics, Inc.
Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Health Technology |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
